These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30981604)

  • 1. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
    Corti G; Bartolini A; Crisafulli G; Novara L; Rospo G; Montone M; Negrino C; Mussolin B; Buscarino M; Isella C; Barault L; Siravegna G; Siena S; Marsoni S; Di Nicolantonio F; Medico E; Bardelli A
    Clin Colorectal Cancer; 2019 Jun; 18(2):91-101.e3. PubMed ID: 30981604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer.
    Siena S; Sartore-Bianchi A; Marsoni S; Hurwitz HI; McCall SJ; Penault-Llorca F; Srock S; Bardelli A; Trusolino L
    Ann Oncol; 2018 May; 29(5):1108-1119. PubMed ID: 29659677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Ross JS; Fakih M; Ali SM; Elvin JA; Schrock AB; Suh J; Vergilio JA; Ramkissoon S; Severson E; Daniel S; Fabrizio D; Frampton G; Sun J; Miller VA; Stephens PJ; Gay LM
    Cancer; 2018 Apr; 124(7):1358-1373. PubMed ID: 29338072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
    Singh H; Sahgal P; Kapner K; Corsello SM; Gupta H; Gujrathi R; Li YY; Cherniack AD; El Alam R; Kerfoot J; Andrews E; Lee A; Nambiar C; Hannigan AM; Remland J; Brais L; Leahy ME; Rubinson DA; Schlechter BL; Meyerson M; Kuang Y; Paweletz CP; Lee JK; Quintanilha JCF; Aguirre AJ; Perez KJ; Huffman BM; Rossi H; Abrams TA; Kabraji S; Trusolino L; Bertotti A; Sicinska ET; Parikh AR; Wolpin BM; Schrock AB; Giannakis M; Ng K; Meyerhardt JA; Hornick JL; Sethi NS; Cleary JM
    Clin Cancer Res; 2024 Apr; 30(8):1669-1684. PubMed ID: 38345769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and clinical application of an integrative genomic approach to personalized cancer therapy.
    Uzilov AV; Ding W; Fink MY; Antipin Y; Brohl AS; Davis C; Lau CY; Pandya C; Shah H; Kasai Y; Powell J; Micchelli M; Castellanos R; Zhang Z; Linderman M; Kinoshita Y; Zweig M; Raustad K; Cheung K; Castillo D; Wooten M; Bourzgui I; Newman LC; Deikus G; Mathew B; Zhu J; Glicksberg BS; Moe AS; Liao J; Edelmann L; Dudley JT; Maki RG; Kasarskis A; Holcombe RF; Mahajan M; Hao K; Reva B; Longtine J; Starcevic D; Sebra R; Donovan MJ; Li S; Schadt EE; Chen R
    Genome Med; 2016 Jun; 8(1):62. PubMed ID: 27245685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of genome scale data for identifying new players in colorectal cancer.
    Sokolova V; Crippa E; Gariboldi M
    World J Gastroenterol; 2016 Jan; 22(2):534-45. PubMed ID: 26811605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
    Taghizadeh H; Zöchbauer-Müller S; Mader RM; Müllauer L; Klikovits T; Bachleitner-Hofmann T; Hoda MA; Prager GW
    Thorac Cancer; 2020 Jul; 11(7):1979-1988. PubMed ID: 32438515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pragmatic nationwide master observational trial based on genomic alterations in advanced solid tumors: KOrean Precision Medicine Networking Group Study of MOlecular profiling guided therapy based on genomic alterations in advanced Solid tumors (KOSMOS)-II study protocol KCSG AL-22-09.
    Kim SY; Kim JH; Kim TY; Park SR; Yoon S; Lee S; Lee SH; Kim TM; Han SW; Kim HR; Yun H; Lee S; Kim J; Choi YL; Choi KS; Chae H; Ryu H; Lee GW; Zang DY; Ahn JB
    BMC Cancer; 2024 May; 24(1):574. PubMed ID: 38724991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology.
    Lorenz J; Rothhammer-Hampl T; Zoubaa S; Bumes E; Pukrop T; Kölbl O; Corbacioglu S; Schmidt NO; Proescholdt M; Hau P; Riemenschneider MJ
    Acta Neuropathol Commun; 2020 Aug; 8(1):124. PubMed ID: 32758285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues.
    Busico A; Gasparini P; Rausa E; Cattaneo L; Bozzi F; Silvestri M; Capone I; Conca E; Tamborini E; Perrone F; Vitellaro M; Ricci MT; Casanova M; Chiaravalli S; Bergamaschi L; Massimino M; Milione M; Sozzi G; Pruneri G; Ferrari A; Signoroni S
    Sci Rep; 2024 Jun; 14(1):13138. PubMed ID: 38849509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive genomic profiling for oncological advancements by precision medicine.
    Pankiw M; Brezden-Masley C; Charames GS
    Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
    Loaiza-Bonilla A; Benson AB; Grothey A; Karimi M; Klempner SJ; Lin D; Mahtani R; Soares HP
    Oncologist; 2021 Aug; 26(8):651-659. PubMed ID: 33650740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a targeted gene sequencing panel for application to disparate cancers.
    McCabe MJ; Gauthier MA; Chan CL; Thompson TJ; De Sousa SMC; Puttick C; Grady JP; Gayevskiy V; Tao J; Ying K; Cipponi A; Deng N; Swarbrick A; Thomas ML; Lord RV; Johns AL; Kohonen-Corish M; O'Toole SA; Clark J; Mueller SA; Gupta R; McCormack AI; Dinger ME; Cowley MJ;
    Sci Rep; 2019 Nov; 9(1):17052. PubMed ID: 31745186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines.
    Woo XY; Srivastava A; Graber JH; Yadav V; Sarsani VK; Simons A; Beane G; Grubb S; Ananda G; Liu R; Stafford G; Chuang JH; Airhart SD; Karuturi RKM; George J; Bult CJ
    BMC Med Genomics; 2019 Jul; 12(1):92. PubMed ID: 31262303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current challenges in the implementation of precision oncology for the management of metastatic colorectal cancer.
    Kim SY; Kim TW
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32188714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation sequencing transforming clinical practice and precision medicine.
    Yadav D; Patil-Takbhate B; Khandagale A; Bhawalkar J; Tripathy S; Khopkar-Kale P
    Clin Chim Acta; 2023 Nov; 551():117568. PubMed ID: 37839516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary Colorectal Cancer Diagnosis by Next-Generation Sequencing.
    Wen T; Ehivet F; Stanislaw C; Mao R; Hegde M
    Curr Protoc; 2023 Dec; 3(12):e941. PubMed ID: 38112503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Next-Generation Sequencing in Precision Oncology.
    Karlovich CA; Williams PM
    Cancer J; 2019; 25(4):264-271. PubMed ID: 31335390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer genomic biomarkers in the clinical management of patients with metastatic colorectal carcinoma.
    Rachiglio AM; Sacco A; Forgione L; Esposito C; Chicchinelli N; Normanno N
    Explor Target Antitumor Ther; 2020; 1(1):53-70. PubMed ID: 36046264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker-guided therapy for colorectal cancer: strength in complexity.
    Sveen A; Kopetz S; Lothe RA
    Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.